Cellectar Biosciences Presents New Preclinical Data

Cellectar Biosciences revealed new preclinical data showing benefits in treatment from multiple doses of the company's leading compounds CLR 131...

Cellectar Receives Patent Approval in Japan

Cellectar Biosciences received clearance by the Japanese Patent Office for two of the company's phospholipid drug conjugates.